Explore our news & Blogs

As HOSPEX INDIA 2023 concluded, mlHealth 360 looked back on three days filled with immense learning, strategic alliances, and state-of-the-art innovations. One of the standout moments for mlHealth 360 was the introduction of SCAIDA, their advanced AI enterprise imaging solution. The enthusiastic reception to SCAIDA reaffirmed the company’s leadership role in health tech advancements. The event was also enriched with expert sessions, offering deep insights into diverse areas from cutting-edge medical technology to the nuances of healthcare digital marketing. These discussions illuminated the path forward for many attendees, shedding light on the future of healthcare technology. Beyond the knowledge exchange, HOSPEX became a hub for nurturing relationships. mlHealth 360 forged significant connections and collaborative opportunities that promise to shape their endeavors in the coming months. Special recognition was given to Vasudhev Health Tech, mlHealth 360’s esteemed partners. “Our experience at HOSPEX was heightened due to our partnership with Vasudhev Health Tech. Their unwavering support was invaluable,” shared a representative from mlHealth 360. In their farewell note to HOSPEX INDIA 2023, mlHealth 360 expressed their heartfelt thanks to the event organizers and the diverse medical community that participated. The company emphasized, “It wasn’t just the new knowledge or the new partnerships but also the rejuvenated zeal towards our mission of integrating technology in healthcare that we take with us.” With fond memories of this year’s event, mlHealth 360 eagerly anticipates HOSPEX 2024.

In a recent announcement, the organizers of the 4th annual Investor Readiness Program (IRP) have chosen mlHealth 360 as one of the standout companies to participate in this esteemed initiative. Spanning six months, the IRP is meticulously designed to bridge promising small and mid-sized enterprises (SMEs) in BC’s vibrant life sciences arena with seasoned Entrepreneurs-in-Residence (EIRs). This connection aims to prime these innovative businesses for investor attraction. The inclusion of mlHealth 360 in this program underlines its potential and the significant strides it has made in the life sciences sector. The organizers took a moment to laud all selected companies for their achievements and extend their gratitude to the EIRs for their commitment to elevating the sector. Further bolstering the program’s stature is the continued support and partnership from the National Research Council Canada/Conseil national de recherches Canada Industrial Research Assistance Program (NRC IRAP).